<DOC>
	<DOCNO>NCT00518271</DOCNO>
	<brief_summary>This study evaluate renal graft function base calculated creatinine clearance 6 month transplantation patient receive regimen 'reduced ' 'standard ' dose tacrolimus plus sirolimus corticosteroid .</brief_summary>
	<brief_title>Study Comparing Standard Dose Reduced Dose Tacrolimus + Sirolimus + Corticosteroids Renal Allograft Recipients</brief_title>
	<detailed_description>This study evaluate renal graft function base calculated creatinine clearance 6 month transplantation patient receive regimen 'reduced ' 'standard ' dose tacrolimus plus sirolimus corticosteroid . Blood serum creatinine , incidence biopsy-confirmed acute graft rejection , patient graft survival also evaluate 6 month post transplantation .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Inclusion criterion At least 18 year age Endstage renal disease patient receive primary secondary renal allograft cadaveric donor Patients secondary kidney transplant must maintain primary graft least 6 month Exclusion criterion Planned antibody induction Multiple organ transplant Patients high risk acute rejection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>